Cite
HARVARD Citation
Atreya, R. et al. (n.d.). S0642 Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial. American journal of gastroenterology. p. S322. [Online].